- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT07913997
Cognitive-Motor Training With the DextEgg in Children With ADHD (ADHD DextEgg)
Investigating the Relationship Between Fine Motor Skills and Cognitive-Motor Training in Children With ADHD: a Randomized Controlled Trial
Attention Deficit Hyperactivity Disorder (ADHD) is frequently accompanied by deficits in executive functions and fine motor skills, which affect daily activities, academic performance, and health-related quality of life. The DextEgg is a gamified hand-training device with motion and pressure sensors that connects to a tablet app and allows fine motor exercises to be combined with cognitive demands (inhibition, working memory, cognitive flexibility). This single-center randomized controlled trial evaluates whether a 4-week home-based cognitive-motor training with the DextEgg improves fine motor skills and executive functions in children aged 8 to 12 years with ADHD, compared with a motor-only DextEgg training of identical dose. Fifty children will be randomized 1:1 and complete 20 home-based sessions (5 per week, 35 minutes each). Assessments take place at baseline, after the intervention, and at 3-month follow-up.
Studieöversikt
Status
Betingelser
Intervention / Behandling
Studietyp
Inskrivning (Beräknad)
Fas
- Inte tillämpbar
Kontakter och platser
Studiekontakt
- Namn: Manuela Pastore-Wapp, PhD
- Telefonnummer: 0412057220
- E-post: manuela.pastore-wapp@unibe.ch
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Beskrivning
Inclusion Criteria:
- Age 8 years 0 months to 12 years 11 months
- Clinical ADHD diagnosis according to DSM-5, confirmed by a physician or psychologist
- Written informed consent by legal guardian and assent by the child
- Caregiver-reported difficulties in fine motor tasks (e.g., handwriting, tying shoes)
- Caregiver-reported executive functioning difficulties in daily life
Exclusion Criteria:
- Any other significant neurological, developmental, or psychiatric condition that could affect fine motor or cognitive functioning
- Participation in another intervention study during the study period
- Inability to follow study procedures due to language difficulties or other barriers
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Behandling
- Tilldelning: Randomiserad
- Interventionsmodell: Parallellt uppdrag
- Maskning: Dubbel
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
|---|---|
|
Experimentell: Cognitive-Motor DextEgg Training
20 home-based sessions over 4 weeks (5x/week, 35 min): finger-specific dexterity exercises with embedded cognitive challenges (inhibition, working memory, cognitive flexibility), adaptive difficulty |
Gamified, app-guided home training with the DextEgg (sensor-equipped hand trainer connected via Bluetooth to a tablet) combining fine motor tasks (tapping, squeezing, rolling) with inhibition, working memory and cognitive-flexibility demands. Other names: Smart Sensor Egg (SSE). |
|
Aktiv komparator: Motor-Only DextEgg Training
Same schedule, device and fine motor tasks, but without embedded cognitive challenge |
Identical fine motor sequences with the DextEgg without dual-task or rule-switching elements; controls for device use, motor activity and training time. |
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Fine motor skills (M-ABC-3 fine motor coordination)
Tidsram: Baseline, post-intervention (week 5), 3-month follow-up
|
Movement Assessment Battery for Children, 3rd edition, fine motor coordination subscale (placing pegs, threading lace, drawing trail) |
Baseline, post-intervention (week 5), 3-month follow-up
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Functional dexterity
Tidsram: Baseline, post-intervention (week 5), 3-month follow-up
|
Functional Dexterity Test (FDT) |
Baseline, post-intervention (week 5), 3-month follow-up
|
|
Inhibitory control
Tidsram: Baseline, post-intervention (week 5), 3-month follow-up
|
D-KEFS Color Word Interference Test, Part III |
Baseline, post-intervention (week 5), 3-month follow-up
|
|
Cognitive flexibility
Tidsram: Baseline, post-intervention (week 5), 3-month follow-up
|
D-KEFS Color Word Interference Test, Part IV |
Baseline, post-intervention (week 5), 3-month follow-up
|
|
Verbal working memory
Tidsram: Baseline, post-intervention (week 5), 3-month follow-up
|
WISC-V Digit Span (forward and backward) |
Baseline, post-intervention (week 5), 3-month follow-up
|
|
Visual working memory
Tidsram: Baseline, post-intervention (week 5), 3-month follow-up
|
WISC-V Picture Span |
Baseline, post-intervention (week 5), 3-month follow-up
|
|
Attention
Tidsram: Baseline, post-intervention (week 5), 3-month follow-up
|
TAP subtests Go/No-Go and Divided Attention |
Baseline, post-intervention (week 5), 3-month follow-up
|
Samarbetspartners och utredare
Sponsor
Samarbetspartners
Studieavstämningsdatum
Studera stora datum
Studiestart (Beräknad)
Primärt slutförande (Beräknad)
Avslutad studie (Beräknad)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Faktisk)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- ADHD DextEgg
- BASEC (Annan identifierare: 2026-00938)
- SNCTP (Annan identifierare: SNCTP000006929)
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .